Expression of CD8, CD86, MHC-class II, and adhesion molecules was found to be increased between 1 and 10 days after LITT at the tumor invasion front as compared to resection or no treatment, indicating an influx of immune cells [128]. The gene discussed is CD8A; the disease is neoplasm.